Syneos Health Reports First Quarter 2021 Results
April 29, 2021 06:16 ET
|
Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
April 20, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021
April 01, 2021 16:01 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial...
Syneos Health Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
March 29, 2021 07:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Science 37, the...
Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent
March 15, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Syneos Health Announces Pricing of Secondary Offering of Common Stock
March 01, 2021 09:28 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health Announces Secondary Offering of Common Stock
March 01, 2021 06:44 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., March 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization...
Syneos Health and Protocol First Partner to Accelerate Collection and Review of Clinical Trial Data
February 24, 2021 09:00 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C. and SALT LAKE CITY, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Protocol First, Inc., a...
Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires
February 23, 2021 09:51 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...
Syneos Health Reports Fourth Quarter and Full Year 2020 Results
February 18, 2021 06:15 ET
|
Syneos Health, Inc.
Highlights GAAP revenue of $1,140.0 million for the three months ended December 31, 2020, representing a sequential increase of 3.7% compared to the three months ended September 30, 2020.Net...